EMD

emerin, the group of LEM domain containing

Basic information

Region (hg38): X:154379273-154381574

Links

ENSG00000102119NCBI:2010OMIM:300384HGNC:3331Uniprot:P50402AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • heart conduction disease (Strong), mode of inheritance: XL
  • X-linked Emery-Dreifuss muscular dystrophy (Definitive), mode of inheritance: XL
  • X-linked Emery-Dreifuss muscular dystrophy (Supportive), mode of inheritance: XL
  • X-linked Emery-Dreifuss muscular dystrophy (Strong), mode of inheritance: XL

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Emery-Dreifuss muscular dystrophy 1, X-linkedXLCardiovascularSurveillance for and treatment of cardiac disease (eg, with EKG), including pacemaker implantation, may be beneficialCardiovascular; Musculoskeletal4567289; 3319295; 2685312; 7894480; 9195226; 10377322; 10323252; 10382910; 20301609; 21496632; 21697856
Individuals, including females, can have serious cardiac conduction defects

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the EMD gene.

  • X-linked Emery-Dreifuss muscular dystrophy (49 variants)
  • not provided (20 variants)
  • Emery-Dreifuss muscular dystrophy 1, X-linked (3 variants)
  • Cardiovascular phenotype (3 variants)
  • Emery-Dreifuss muscular dystrophy (1 variants)
  • EMD-related disorder (1 variants)
  • Neuromuscular disease (1 variants)
  • Myopathy;Flexion contracture;Failure to thrive (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the EMD gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
116
clinvar
1
clinvar
121
missense
1
clinvar
1
clinvar
142
clinvar
11
clinvar
2
clinvar
157
nonsense
19
clinvar
4
clinvar
23
start loss
3
clinvar
3
frameshift
30
clinvar
10
clinvar
2
clinvar
42
inframe indel
1
clinvar
7
clinvar
8
splice donor/acceptor (+/-2bp)
9
clinvar
6
clinvar
15
splice region
1
10
17
1
29
non coding
1
clinvar
71
clinvar
7
clinvar
79
Total 62 22 156 198 10

Highest pathogenic variant AF is 0.00000887

Variants in EMD

This is a list of pathogenic ClinVar variants found in the EMD region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
X-154379314-CGTGACGCGACAACGATTCGGCT-C X-linked Emery-Dreifuss muscular dystrophy • EMD-related disorder Likely benign (Nov 17, 2022)1215766
X-154379351-A-G Likely benign (Jul 09, 2018)1209222
X-154379368-G-A EMD-related disorder Likely benign (May 05, 2021)3057492
X-154379461-C-T not specified Likely benign (Mar 13, 2017)382185
X-154379478-A-C Uncertain significance (Jan 24, 2017)193046
X-154379485-A-G X-linked Emery-Dreifuss muscular dystrophy Pathogenic (Jun 19, 2019)11172
X-154379486-T-G X-linked Emery-Dreifuss muscular dystrophy Pathogenic (Oct 02, 2020)1074958
X-154379487-G-A X-linked Emery-Dreifuss muscular dystrophy Pathogenic (Jul 05, 2022)281087
X-154379493-C-T X-linked Emery-Dreifuss muscular dystrophy Likely benign (Mar 06, 2022)2107259
X-154379496-C-A X-linked Emery-Dreifuss muscular dystrophy Pathogenic (May 28, 2019)804132
X-154379496-C-G X-linked Emery-Dreifuss muscular dystrophy Pathogenic (Jul 09, 2019)462823
X-154379496-C-T X-linked Emery-Dreifuss muscular dystrophy • Emery-Dreifuss muscular dystrophy • Cardiovascular phenotype • EMD-related disorder • Cardiomyopathy Conflicting classifications of pathogenicity (Jan 05, 2024)290626
X-154379499-A-G X-linked Emery-Dreifuss muscular dystrophy Likely benign (Apr 12, 2022)1543558
X-154379499-AG-A X-linked Emery-Dreifuss muscular dystrophy Likely pathogenic (Oct 08, 2018)617592
X-154379502-T-A Cardiovascular phenotype Uncertain significance (Mar 08, 2022)1782290
X-154379503-C-T Dilated cardiomyopathy 1A Uncertain significance (Oct 21, 2019)978372
X-154379503-CT-C X-linked myopathy with postural muscle atrophy Pathogenic (Feb 13, 2024)3024542
X-154379504-T-A X-linked Emery-Dreifuss muscular dystrophy Uncertain significance (Nov 03, 2021)201778
X-154379507-C-G Primary dilated cardiomyopathy • X-linked Emery-Dreifuss muscular dystrophy Uncertain significance (Jul 24, 2023)222597
X-154379507-C-T X-linked Emery-Dreifuss muscular dystrophy Uncertain significance (Nov 03, 2021)1496459
X-154379514-C-G X-linked Emery-Dreifuss muscular dystrophy • Cardiovascular phenotype Likely benign (Sep 23, 2023)1097205
X-154379514-C-T X-linked Emery-Dreifuss muscular dystrophy Likely benign (Apr 24, 2022)2130003
X-154379515-G-A X-linked Emery-Dreifuss muscular dystrophy Uncertain significance (Jun 25, 2022)1060231
X-154379516-A-G X-linked Emery-Dreifuss muscular dystrophy Uncertain significance (Jun 15, 2022)2006904
X-154379517-G-A X-linked Emery-Dreifuss muscular dystrophy • Cardiovascular phenotype Likely benign (Dec 20, 2023)1131752

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
EMDprotein_codingprotein_codingENST00000369842 62327
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9320.067900000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.1651151101.040.000008861642
Missense in Polyphen3237.2780.85842558
Synonymous-2.426443.71.470.00000335511
Loss of Function2.7108.550.005.43e-7152

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Stabilizes and promotes the formation of a nuclear actin cortical network. Stimulates actin polymerization in vitro by binding and stabilizing the pointed end of growing filaments. Inhibits beta-catenin activity by preventing its accumulation in the nucleus. Acts by influencing the nuclear accumulation of beta- catenin through a CRM1-dependent export pathway. Links centrosomes to the nuclear envelope via a microtubule association. EMD and BAF are cooperative cofactors of HIV-1 infection. Association of EMD with the viral DNA requires the presence of BAF and viral integrase. The association of viral DNA with chromatin requires the presence of BAF and EMD. Required for proper localization of non-farnesylated prelamin-A/C. {ECO:0000269|PubMed:15328537, ECO:0000269|PubMed:16680152, ECO:0000269|PubMed:16858403, ECO:0000269|PubMed:17785515, ECO:0000269|PubMed:19323649}.;
Disease
DISEASE: Emery-Dreifuss muscular dystrophy 1, X-linked (EDMD1) [MIM:310300]: A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects. {ECO:0000269|PubMed:10323252, ECO:0000269|PubMed:11587540, ECO:0000269|PubMed:15009215, ECO:0000269|PubMed:15328537}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Dilated cardiomyopathy (DCM) - Homo sapiens (human);Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Arrhythmogenic Right Ventricular Cardiomyopathy;Clearance of Nuclear Envelope Membranes from Chromatin;Nuclear Envelope Breakdown;Mitotic Prophase;Initiation of Nuclear Envelope Reformation;Nuclear Envelope Reassembly;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic (Consensus)

Recessive Scores

pRec
0.537

Intolerance Scores

loftool
rvis_EVS
-0.05
rvis_percentile_EVS
49.76

Haploinsufficiency Scores

pHI
0.0626
hipred
Y
hipred_score
0.701
ghis
0.462

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.493

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Emd
Phenotype
homeostasis/metabolism phenotype; muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Gene ontology

Biological process
muscle contraction;mitotic nuclear envelope reassembly;muscle organ development;skeletal muscle cell differentiation;positive regulation of protein export from nucleus;negative regulation of fibroblast proliferation;regulation of canonical Wnt signaling pathway;cellular response to growth factor stimulus;negative regulation of canonical Wnt signaling pathway
Cellular component
nuclear envelope;nuclear inner membrane;nuclear outer membrane;nucleoplasm;cytoplasm;endoplasmic reticulum;spindle;microtubule;membrane;integral component of membrane;spindle pole centrosome;nuclear membrane;cortical endoplasmic reticulum
Molecular function
actin binding;protein binding;cadherin binding;beta-tubulin binding